Melanoma subsequent to natalizumab exposure: A report from the RADAR (Research on Adverse Drug events And Reports) program

被引：7
|
作者：
Kelm, Ryan C. [1 ]
Hagstrom, Erika L. [1 ]
Mathieu, Regine J. [1 ]
Orrell, Kelsey A. [1 ]
Serrano, Linda [1 ]
Mueller, Kelly A. [1 ]
Laumann, Anne E. [1 ]
West, Dennis P. [1 ,2 ]
Nardone, Beatrice [1 ]
机构：
[1] Northwestern Univ, Dept Dermatol, Chicago, IL 60611 USA
[2] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2019年 / 80卷 / 03期
基金：
美国国家卫生研究院;
关键词：
COMPLICATING TREATMENT;
D O I：
10.1016/j.jaad.2018.10.052
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：820 / 821
页数：3
相关论文
共 50 条
  • [21] Inflammatory bowel disease events after exposure to the inter-leukin-17 inhibitors ixekizumab and secukinumab: A report from the RADAR (Research on Adverse Drug Events and Reports) project
    Orrell, Kelsey A.
    Murphrey, Morgan
    Lee, Harrison H.
    Pease, David R.
    West, Dennis P.
    Nardone, Beatrice
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB168 - AB168
  • [22] The Rresearch on Adverse Drug Events and Reports (RADAR) project
    Bennett, CL
    Nebeker, JR
    Lyons, EA
    Samore, MH
    Feldman, MD
    McKoy, JM
    Carson, KR
    Belknap, SM
    Trifilio, SM
    Schumock, GT
    Yarnold, PR
    Davidson, CJ
    Evens, AM
    Kuzel, TM
    Parada, JP
    Cournoyer, D
    West, DP
    Sartor, O
    Tallman, MS
    Raisch, DW
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (17): : 2131 - 2140
  • [23] Incidence of cutaneous T-cell lymphoma (CTCL) after chronic exposure to thiazides: pharmacovigilance analysis from the RADAR (Research on Adverse Drug events And Reports) Program
    Pease, David R.
    Martinez-Escala, Maria Estela
    Jimenez, Javier
    Guitart, Joan
    West, Dennis P.
    Nardone, Beatrice
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB226 - AB226
  • [24] Melanoma and non-melanoma skin cancer associated with antihypertensive drugs: A report from the Research on Adverse Drug events and Reports project B
    Nardone
    Kim, A. S.
    Majewski, S.
    Laumann, A. E.
    Rademaker, A.
    West, D. P.
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2015, 56 (04) : A3 - A4
  • [25] Melanoma associated with TNFα inhibitors: A research on adverse drug reactions (RADAR) report
    Nardone, Beatrice
    West, Dennis P.
    Raisch, Dennis W.
    Abramovici, Gil
    Reserva, Jeave
    Hammel, Josh A.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB1 - AB1
  • [26] Zoledronic acid (ZA) - Associated nephrotoxicity: An analysis of adverse drug reaction (ADR) reports by the research on adverse drug events and reports (RADAR) project
    McKoy, JM
    Obadina, E
    Yarnold, PR
    Kut, V
    Raisch, DW
    Bennett, CL
    [J]. BLOOD, 2004, 104 (11) : 858A - 858A
  • [27] Cerebrovascular accident events associated with IL-23 inhibition: Pharmacovigilance analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) from the RADAR (Research on Adverse Drug Events And Reports) Program
    Kahen, Negar
    Ali, Yasmeen
    West, Dennis P.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB27 - AB27
  • [28] Risk of Anaphylaxis with Repeated Courses of Rasburicase: A Research on Adverse Drug Events and Reports (RADAR) Project
    Allen, Katherine C.
    Champlain, Amanda H.
    Cotliar, Jonathan A.
    Belknap, Steven M.
    West, Dennis P.
    Mehta, Jayesh
    Trifilio, Steven M.
    [J]. DRUG SAFETY, 2015, 38 (02) : 183 - 187
  • [29] Risk of Anaphylaxis with Repeated Courses of Rasburicase: A Research on Adverse Drug Events and Reports (RADAR) Project
    Katherine C. Allen
    Amanda H. Champlain
    Jonathan A. Cotliar
    Steven M. Belknap
    Dennis P. West
    Jayesh Mehta
    Steven M. Trifilio
    [J]. Drug Safety, 2015, 38 : 183 - 187
  • [30] Monoclonal anti body-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project
    Carson, Kenneth R.
    Focosi, Daniele
    Major, Eugene O.
    Petrini, Mario
    Richey, Elizabeth A.
    West, Dennis P.
    Bennett, Charles L.
    [J]. LANCET ONCOLOGY, 2009, 10 (08): : 816 - 824
12345